Tuesday, September 16, 2025

The Latest Medical News

A Summary of The Latest Medical News: Two existing cancer drugs — letrozole and irinotecan — have shown **potential to reverse brain changes caused by Alzheimer’s disease** in mouse models[1][2]. ** **How the Research Was Done** Scientists at UCSF and Gladstone Institutes first studied how Alzheimer’s disease changes gene activity in different brain cells, like neurons and glia. They then searched for **FDA-approved drugs that could reverse those specific gene changes**[2]. ** **Identifying Promising Drug Candidates** Out of numerous possibilities, **letrozole (a breast cancer drug) and irinotecan (a colon and lung cancer drug) stood out** for their effects in reversing gene expression linked with Alzheimer’s in neurons and glia, respectively[1][2]. ** **What Happened in Mouse Models** Giving mice either drug alone did not have a strong impact on the accumulation of tau protein clumps, which are a hallmark of Alzheimer’s. However, **when the drugs were used together, the results were dramatic**. The **combination reduced toxic tau clumps, lessened brain degeneration, and improved memory and learning in the affected animals**[1][2]. ** **Why a Combination Works** The researchers explained that **Alzheimer’s disrupts many genes and proteins**, so a single drug is usually insufficient. By targeting both neurons and glia with two drugs, they could fight the disease’s complexity more effectively[1][2]. ** **From Laboratory to Potential Treatment** While these results are promising, both letrozole and irinotecan have significant side effects, and they were only tested in mice so far. **Clinical trials in humans** are needed to see if this drug combination can help Alzheimer’s patients safely and effectively[1][2]. ** **A New Approach for Alzheimer’s** Researchers are hopeful that their **computational approach — using big data to match drugs with precise brain changes — could offer more personalized and effective therapies for Alzheimer’s and similar diseases**[2]. ** **What’s Next** If these findings translate to humans, millions of people living with Alzheimer’s could potentially benefit from this new drug combination. The hope is that **clinical trials will be launched soon to test the safety and effectiveness of letrozole and irinotecan in Alzheimer’s patients**[1][2]. Help with your insurance? https://tally.so/r/n012P9

No comments:

Post a Comment